Folate-appended β-cyclodextrin as a promising tumor targeting carrier for antitumor drugs in vitro and in vivo

Bioconjugate Chemistry

Volumn 24, Issue 4, 2013, Pages 724-733

  Okamatsu, Ayaka ^a   Motoyama, Keiichi ^a   Onodera, Risako ^a   Higashi, Taishi ^a   Koshigoe, Takahiro ^b   Shimada, Yasutaka ^c   Hattori, Kenjiro ^b,c   Takeuchi, Tomoko ^b   Arima, Hidetoshi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b TOKYO POLYTECHNIC UNIVERSITY   (Japan)

^c RandD Lab   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELLS; CONTROLLED DRUG DELIVERY; DRUG PRODUCTS; TARGETED DRUG DELIVERY; TUMORS;

ANTITUMOR DRUGS; ANTITUMOUR ACTIVITY; CELL LINES; DOXORUBICIN; DRUG CARRIER; FOLATE RECEPTOR; FOLATES; FOLIC ACIDS; IN-VITRO; TUMOR-TARGETING;

CYCLODEXTRINS;

ANTINEOPLASTIC AGENT; BETA CYCLODEXTRIN; DOXORUBICIN; DRUG CARRIER; FOLATE RECEPTOR 1; FOLIC ACID; HEPTAKIS 6 FOLIC ACID; PACLITAXEL; UNCLASSIFIED DRUG; VINBLASTINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL TRANSPORT; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENCAPSULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INOCULATION; MALE; MOUSE; NONHUMAN;

MUS;

EID: 84876495719     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc400015r     Document Type: Article

References (56)

1. Danhier, F., Feron, O., and Preat, V. (2010) To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery J. Controlled Release 148, 135-146
2. Matsumura, Y. and Maeda, H. (1986) A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs Cancer Res. 46, 6387-6392
3. Talekar, M., Kendall, J., Denny, W., and Garg, S. (2011) Targeting of nanoparticles in cancer: drug delivery and diagnostics Anticancer Drugs 22, 949-962
4. Hong, R. L., Huang, C. J., Tseng, Y. L., Pang, V. F., Chen, S. T., Liu, J. J., and Chang, F. H. (1999) Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial? Clin. Cancer Res. 5, 3645-3652
5. Maruyama, K. (2011) Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects Adv. Drug Delivery Rev. 63, 161-169
6. Schiffelers, R. M., Koning, G. A., ten Hagen, T. L., Fens, M. H., Schraa, A. J., Janssen, A. P., Kok, R. J., Molema, G., and Storm, G. (2003) Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin J. Controlled Release 91, 115-122
7. Roche, A. C., Fajac, I., Grosse, S., Frison, N., Rondanino, C., Mayer, R., and Monsigny, M. (2003) Glycofection: facilitated gene transfer by cationic glycopolymers Cell. Mol. Life Sci. 60, 288-297
8. Hatakeyama, H., Akita, H., Maruyama, K., Suhara, T., and Harashima, H. (2004) Factors governing the in vivo tissue uptake of transferrin-coupled polyethylene glycol liposomes in vivo Int. J. Pharm. 281, 25-33
9. Miyajima, Y., Nakamura, H., Kuwata, Y., Lee, J. D., Masunaga, S., Ono, K., and Maruyama, K. (2006) Transferrin-loaded nido-carborane liposomes: tumbetaor-targeting boron delivery system for neutron capture therapy Bioconjugate Chem. 17, 1314-1320
10. Harata, M., Soda, Y., Tani, K., Ooi, J., Takizawa, T., Chen, M., Bai, Y., Izawa, K., Kobayashi, S., Tomonari, A., Nagamura, F., Takahashi, S., Uchimaru, K., Iseki, T., Tsuji, T., Takahashi, T. A., Sugita, K., Nakazawa, S., Tojo, A., Maruyama, K., and Asano, S. (2004) CD19-targeting liposomes containing imatinib efficiently kill Philadelphia chromosome-positive acute lymphoblastic leukemia cells Blood 104, 1442-1449
11. Sugahara, K. N., Teesalu, T., Karmali, P. P., Kotamraju, V. R., Agemy, L., Girard, O. M., Hanahan, D., Mattrey, R. F., and Ruoslahti, E. (2009) Tissue-penetrating delivery of compounds and nanoparticles into tumors Cancer Cell 16, 510-520
12. Sugahara, K. N., Teesalu, T., Karmali, P. P., Kotamraju, V. R., Agemy, L., Greenwald, D. R., and Ruoslahti, E. (2010) Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs Science 328, 1031-1035
13. Chen, H., Ahn, R., Van den Bossche, J., Thompson, D. H., and O'Halloran, T. V. (2009) Folate-mediated intracellular drug delivery increases the anticancer efficacy of nanoparticulate formulation of arsenic trioxide Mol. Cancer Ther. 8, 1955-1963
14. Lu, Y. and Low, P. S. (2002) Folate-mediated delivery of macromolecular anticancer therapeutic agents Adv. Drug Delivery Rev. 54, 675-693
15. Leamon, C. P. and Low, P. S. (2001) Folate-mediated targeting: from diagnostics to drug and gene delivery Drug Discovery Today 6, 44-51
16. Parker, N., Turk, M. J., Westrick, E., Lewis, J. D., Low, P. S., and Leamon, C. P. (2005) Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay Anal. Biochem. 338, 284-293
17. Gabizon, A., Tzemach, D., Gorin, J., Mak, L., Amitay, Y., Shmeeda, H., and Zalipsky, S. (2010) Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models Cancer Chemother. Pharmacol. 66, 43-52
18. Riviere, K., Huang, Z., Jerger, K., Macaraeg, N., and Szoka, F. C., Jr. (2011) Antitumor effect of folate-targeted liposomal doxorubicin in KB tumor-bearing mice after intravenous administration J. Drug Targeting 19, 14-24
19. Watanabe, K., Kaneko, M., and Maitani, Y. (2012) Functional coating of liposomes using a folate-polymer conjugate to target folate receptors Int. J. Nanomed. 7, 3679-3688
20. Wang, Y., Cao, X., Guo, R., Shen, M., Zhang, M., Zhu, M., and Shi, X. (2011) Targeted delivery of doxorubicin into cancer cells using a folic acid-dendrimer conjugate Polym. Chem. 2, 1754-1760
21. Sahu, S. K., Mallick, S. K., Santra, S., Maiti, T. K., Ghosh, S. K., and Pramanik, P. (2010) In vitro evaluation of folic acid modified carboxymethyl chitosan nanoparticles loaded with doxorubicin for targeted delivery J. Mater. Sci. Mater. Med. 21, 1587-1597
22. Scomparin, A., Salmaso, S., Bersani, S., Satchi-Fainaro, R., and Caliceti, P. (2011) Novel folated and non-folated pullulan bioconjugates for anticancer drug delivery Eur. J. Pharm. Sci. 42, 547-558
23. Kim, D., Lee, E. S., Oh, K. T., Gao, Z. G., and Bae, Y. H. (2008) Doxorubicin-loaded polymeric micelle overcomes multidrug resistance of cancer by double-targeting folate receptor and early endosomal pH Small 4, 2043-2050
24. Leamon, C. P., Reddy, J. A., Vlahov, I. R., Westrick, E., Parker, N., Nicoson, J. S., and Vetzel, M. (2007) Comparative preclinical activity of the folate-targeted Vinca alkaloid conjugates EC140 and EC145 Int. J. Cancer 121, 1585-1592
25. Hirayama, F. and Uekama, K. (1999) Cyclodextrin-based controlled drug release system Adv. Drug Delivery Rev. 36, 125-141
26. Li, J. J., Zhao, F., and Li, J. (2011) Supramolecular polymers based on cyclodextrins for drug and gene delivery Adv. Biochem. Eng. Biotechnol. 125, 207-249
27. Szejtli, J. (1994) Medicinal applications of cyclodextrins Med. Res. Rev. 14, 353-386
28. Szente, L. and Szejtli, J. (1999) Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development Adv. Drug Delivery Rev. 36, 17-28
29. Uekama, K., Hirayama, F., and Irie, T. (1998) Cyclodextrin drug carrier systems Chem. Rev. 98, 2045-2076
30. Salmaso, S., Semenzato, A., Caliceti, P., Hoebeke, J., Sonvico, F., Dubernet, C., and Couvreur, P. (2004) Specific antitumor targetable β-cyclodextrin-poly(ethylene glycol)-folic acid drug delivery bioconjugate Bioconjugate Chem. 15, 997-1004
31. Caliceti, P., Salmaso, S., Semenzato, A., Carofiglio, T., Fornasier, R., Fermeglia, M., Ferrone, M., and Pricl, S. (2003) Synthesis and physicochemical characterization of folate-cyclodextrin bioconjugate for active drug delivery Bioconjugate Chem. 14, 899-908
32. Zhang, H., Cai, Z., Sun, Y., Yu, F., Chen, Y., and Sun, B. (2012) Folate-conjugated β-cyclodextrin from click chemistry strategy and for tumor-targeted drug delivery J. Biomed. Mater. Res. A 100, 2441-2449
33. Stella, V. J. and He, Q. (2008) Cyclodextrins Toxicol. Pathol. 36, 30-42
34. Ooya, T., Eguchi, M., and Yui, N. (2003) Supramolecular design for multivalent interaction: maltose mobility along polyrotaxane enhanced binding with concanavalin A J. Am. Chem. Soc. 125, 13016-13017
35. Ooya, T., Utsunomiya, H., Eguchi, M., and Yui, N. (2005) Rapid binding of concanavalin A and maltose-polyrotaxane conjugates due to mobile motion of α-cyclodextrins threaded onto a poly(ethylene glycol) Bioconjugate Chem. 16, 62-69
36. Abe, H., Kenmoku, A., Yamaguch, N., and Hattori, K. (2002) Structural effects of oligosaccharide-branched cyclodextrins on the dual recognition toward lectin and drug J. Incl. Phenom. Macrocycl. Chem. 44, 39-47
37. Hattori, K., Kenmoku, A., Mizuguchi, T., Ikeda, D., Mizuno, M., and Inazu, T. (2006) Saccharide-branched Cyclodextrins as Targeting Drug Carriers J. Incl. Phenom. Macrocycl. Chem. 56, 9-16
38. Oda, Y., Kobayashi, N., Yamanoi, T., Katsuraya, K., Takahashi, K., and Hattori, K. (2008) β-Cyclodextrin conjugates with glucose moieties designed as drug carriers: their syntheses, evaluations using concanavalin A and doxorubicin, and structural analyses by NMR spectroscopy Med. Chem. 4, 244-255
39. Oda, Y., Yanagisawa, H., Maruyama, M., Hattori, K., and Yamanoi, T. (2008) Design, synthesis and evaluation of D-galactose-β-cyclodextrin conjugates as drug-carrying molecules Bioorg. Med. Chem. 16, 8830-8840
40. Yamanoi, T., Yoshida, N., Oda, Y., Akaike, E., Tsutsumida, M., Kobayashi, N., Osumi, K., Yamamoto, K., Fujita, K., Takahashi, K., and Hattori, K. (2005) Synthesis of mono-glucose-branched cyclodextrins with a high inclusion ability for doxorubicin and their efficient glycosylation using Mucor hiemalis endo-β-N-acetylglucosaminidase Bioorg. Med. Chem. Lett. 15, 1009-1013
41. Job, P. (1928) Formation and stability of inorganic complexes in solution Ann. Chim. 9, 113-203
42. Scott, R. L. (1956) Some comments on the Benesi-Hildebrand equation Rec. Trav. Chim. 75, 787-789
43. Arima, H., Chihara, Y., Arizono, M., Yamashita, S., Wada, K., Hirayama, F., and Uekama, K. (2006) Enhancement of gene transfer activity mediated by mannosylated dendrimer/α-cyclodextrin conjugate (generation 3, G3) J. Controlled Release 116, 64-74
44. Wada, K., Arima, H., Tsutsumi, T., Chihara, Y., Hattori, K., Hirayama, F., and Uekama, K. (2005) Improvement of gene delivery mediated by mannosylated dendrimer/α-cyclodextrin conjugates J. Controlled Release 104, 397-413
45. Hamasaki, K., Kogure, K., and Ohwada, K. (1996) A biological method for the quantitative measurement of tetrodotoxin (TTX): tissue culture bioassay in combination with a water-soluble tetrazolium salt Toxicon 34, 490-495
46. Ono, N., Arima, H., Hirayama, F., and Uekama, K. (2001) A moderate interaction of maltosyl-α-cyclodextrin with Caco-2 cells in comparison with the parent cyclodextrin Biol. Pharm. Bull. 24, 395-402
47. Yang, J., Chen, H., Vlahov, I. R., Cheng, J. X., and Low, P. S. (2007) Characterization of the pH of folate receptor-containing endosomes and the rate of hydrolysis of internalized acid-labile folate-drug conjugates J. Pharmacol. Exp. Ther. 321, 462-468
48. Stella, V. J., Rao, V. M., Zannou, E. A., and Zia, V. V. (1999) Mechanisms of drug release from cyclodextrin complexes Adv. Drug Delivery Rev. 36, 3-16
49. Ghaghada, K. B., Saul, J., Natarajan, J. V., Bellamkonda, R. V., and Annapragada, A. V. (2005) Folate targeting of drug carriers: a mathematical model J. Controlled Release 104, 113-128
50. Riganti, C., Voena, C., Kopecka, J., Corsetto, P. A., Montorfano, G., Enrico, E., Costamagna, C., Rizzo, A. M., Ghigo, D., and Bosia, A. (2011) Liposome-encapsulated doxorubicin reverses drug resistance by inhibiting P-glycoprotein in human cancer cells Mol. Pharm. 8, 683-700
51. Roger, E., Kalscheuer, S., Kirtane, A., Guru, B. R., Grill, A. E., Whittum-Hudson, J., and Panyam, J. (2012) Folic acid functionalized nanoparticles for enhanced oral drug delivery Mol. Pharm. 9, 2103-2110
52. Yunomae, K., Arima, H., Hirayama, F., and Uekama, K. (2003) Involvement of cholesterol in the inhibitory effect of dimethyl-β-cyclodextrin on P-glycoprotein and MRP2 function in Caco-2 cells FEBS Lett. 536, 225-231
53. Wen, J. Q. and Cui, W. (1990) Studies on the composition and stability constant of inclusion complexes of β-cyclodextrin with fluorouracil and ftorafur by NMR Yao Xue Xue Bao 25, 345-348
54. Upadhyay, A. K., Singh, S., Chhipa, R. R., Vijayakumar, M. V., Ajay, A. K., and Bhat, M. K. (2006) Methyl-β-cyclodextrin enhances the susceptibility of human breast cancer cells to carboplatin and 5-fluorouracil: involvement of Akt, NF-κB and Bcl-2 Toxicol. Appl. Pharmacol. 216, 177-185
55. Soliman, H. A. and Olesen, H. (1976) Folic acid binding by human plasma albumin Scand. J. Clin. Lab. Invest. 36, 299-304
56. Antony, A. C. (1992) The biological chemistry of folate receptors Blood 79, 2807-2820